Clinical Trial Update: Early Metabolic Resuscitation for Septic Shock [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating early metabolic resuscitation for septic shock was terminated, with results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Organ Dysfunction Syndrome
• Sepsis
• Septic Shock

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Multiple Organ Failure, Septic Shock | Phase 2 | Status: TERMINATED | Results posted: 2021-04-08